Coblopasvir Hydrochloride Capsule 60?mg Low price comparison

DescriptionCoblopasvir (generic name for ??????) is a first-in-class NS5A inhibitor approved in China under brand name Kailiwei (NMPA H20200001). It is primarily studied in research for chronic Hepatitis?C virus (HCV) infection mechanisms, antiviral activity, drug resistance, and NS5A protein-targeted therapeutics. Each box contains 28 capsules (60?mg × 7 capsules × 4 packs), intended solely for laboratory research use—not for clinical, diagnostic, or veterinary applications. Contents hide 1 Product Specifications 2 Background & Mechanism 3 Research Applications 4 Safety & Handling 5 Core Keywords 6 Research Use Disclaimer Product SpecificationsParameterDetailsProduct NameCoblopasvir Hydrochloride Capsule (Kailiwei)Generic NameCoblopasvir Hydrochloride (??????)Dosage FormCapsuleStrength60?mg per capsulePackaging Unit28 capsules (7 × 4 blisters)Approval NumberChina NMPA H20200001Product Code86909640000053ManufacturerBeijing Kaiyin Technology Co., Ltd.Barcode6973059170007Intended UseLaboratory research onlyBackground & MechanismNS5A inhibitor: Coblopasvir specifically targets the HCV NS5A protein, disrupting viral replication and assemblyFirst-in-class innovation: Approved February 2020 through NMPA’s priority review procedure as China’s first Category?1 antiviral drug .Research ApplicationsMechanistic studies of HCV NS5A protein interferencePreclinical antiviral assays & resistance profilingCombination studies with other direct-acting antivirals (e.g., Sofosbuvir)Pharmacokinetics and cellular uptake research in hepatocyte modelsSafety & HandlingAdministration in humans: Not applicable—strictly for in vitro or animal model researchStorage: Store sealed below 30?°C in a dry environmentHandling: Use PPE (lab coat, gloves), avoid ingestion and inhalationWaste Disposal: Follow institutional biosafety and hazardous waste protocolsCore KeywordsCoblopasvir capsule, Kailiwei capsule, Coblopasvir hydrochloride, NS5A inhibitor, HCV research capsule, lab-grade antiviral, Beijing Kaiyin antiviral, antiviral research compound, wholesale antiviral research useResearch Use DisclaimerThis product is intended exclusively for laboratory research. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may result in safety risks. Please adhere to institutional biosafety guidelines and all applicable laws.